Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMD vs MRNA✓SelectedUSD · MRNAAMD vs MRNA performance historyLatest closeAs of-13.25%11/20
Stock and ETF performance explorer

AMD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,080.8%
MRNA return
+786.4%
Excess return
+1,294.5%
Maximum drawdown
-65.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-13.2%-2.2%-11.1%-13.0%
7D-20.5%-12.7%-7.8%-19.5%
30D-23.2%-20.7%-2.5%-21.5%
3M-9.6%+46.3%-55.9%-12.9%
6M-5.2%+305.2%-310.4%-26.1%
YTD+98.2%+561.2%-463.1%+41.5%
1Y+106.0%+772.1%-666.1%+40.2%
3Y+249.2%+147.0%+102.2%+175.4%
5Y+173.1%-26.1%+199.2%+144.6%
All+2,080.8%+786.4%+1,294.5%+1,171.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling